Skip to main content

Geron to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a fireside chat in person at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA, on Thursday, June 15, 2023 at 8:40 a.m. PT.

A webcast of the presentation will be available through the Investor Relations section of Geron’s website under Events. Following the presentation, the webcast will be archived and available for replay for a period of 30 days.

About Geron

Geron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases. To learn more, visit http://www.geron.com/ or follow us on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.36
-4.67 (-2.10%)
AAPL  260.61
-2.16 (-0.82%)
AMD  230.09
-7.94 (-3.34%)
BAC  50.81
-0.71 (-1.37%)
GOOG  253.40
+2.06 (0.82%)
META  731.78
-1.49 (-0.20%)
MSFT  522.52
+4.86 (0.94%)
NVDA  179.58
-1.58 (-0.87%)
ORCL  271.24
-3.91 (-1.42%)
TSLA  434.93
-7.67 (-1.73%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.